Losartan for Improved Vascular Endothelial Function After Preeclampsia
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Losartan for Improved Vascular Endothelial Function After Preeclampsia is a clinical trial[1].
Key Facts
- Losartan for Improved Vascular Endothelial Function After Preeclampsia is in the country of United States[2].
- Losartan for Improved Vascular Endothelial Function After Preeclampsia's instance of is recorded as clinical trial[3].
- Losartan for Improved Vascular Endothelial Function After Preeclampsia's start time is recorded as +2020-11-30T00:00:00Z[4].
- Losartan for Improved Vascular Endothelial Function After Preeclampsia's end time is recorded as +2022-07-31T00:00:00Z[5].
- Losartan for Improved Vascular Endothelial Function After Preeclampsia's main subject is recorded as pre-eclampsia[6].
- Losartan for Improved Vascular Endothelial Function After Preeclampsia's number of participants is recorded as {'unit': '1', 'amount': '+20'}[7].
- Losartan for Improved Vascular Endothelial Function After Preeclampsia's title is recorded as Angiotensin II Receptor Inhibition to Improve Microvascular Function in Women Who Have Had Preeclampsia[8].
- Losartan for Improved Vascular Endothelial Function After Preeclampsia's short name is recorded as LIVE-PE[9].
- Losartan for Improved Vascular Endothelial Function After Preeclampsia's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[10].
- Losartan for Improved Vascular Endothelial Function After Preeclampsia's ClinicalTrials.gov ID is recorded as NCT04632589[11].
- Losartan for Improved Vascular Endothelial Function After Preeclampsia's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+50'}[12].
- Losartan for Improved Vascular Endothelial Function After Preeclampsia's research intervention is recorded as losartan[13].
- Losartan for Improved Vascular Endothelial Function After Preeclampsia's clinical trial phase is recorded as phase I clinical trial[14].
- Losartan for Improved Vascular Endothelial Function After Preeclampsia's research site is recorded as University of Iowa Health Care[15].
- Losartan for Improved Vascular Endothelial Function After Preeclampsia's research subject recruitment status is recorded as recruiting[16].
- Losartan for Improved Vascular Endothelial Function After Preeclampsia's study type is recorded as interventional study[17].